BridgeBio Pharma Inc (BBIO.O)

+ 收藏

资产负债表(BridgeBio Pharma Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
截止日期 2025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 1231123112311231123112311231
原始币种 美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见266,324,000.00407,958,000.00475,222,000.00
 受限制存款及现金流动(元) ---会员可见139,409,000.00139,409,000.00131,000.00
 应收账款及票据(元) 会员可见会员可见会员可见会员可见478,000.00660,000.00235,494,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见38,367,000.0028,396,000.0028,108,000.00
 存货(元) 会员可见会员可见会员可见----
 短期投资(元) 会员可见会员可见---39,813,000.0044,469,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见444,578,000.00616,236,000.00783,424,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见8,701,000.009,840,000.0011,414,000.00
 无形资产(元) 会员可见会员可见会员可见会员可见24,525,000.0025,123,000.0025,721,000.00
 长期投资(元) 会员可见会员可见会员可见会员可见160,443,000.00117,006,000.00-
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见26,730,000.0026,170,000.0028,774,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见220,399,000.00178,139,000.0065,909,000.00
总资产(元) 会员可见会员可见会员可见会员可见664,977,000.00794,375,000.00849,333,000.00
流动负债:
 融资租赁负债流动(元) 会员可见会员可见会员可见会员可见4,600,000.004,623,000.004,544,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见13,363,000.0018,126,000.004,728,000.00
 应付薪酬和福利(元) 会员可见会员可见会员可见会员可见43,541,000.0029,056,000.0032,395,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见65,941,000.0067,461,000.0085,853,000.00
 递延收入流动(元) 会员可见会员可见会员可见会员可见11,771,000.0015,098,000.0013,957,000.00
 流动负债其他项目(元) 会员可见会员可见会员可见----
 流动负债合计(元) 会员可见会员可见会员可见会员可见139,216,000.00134,364,000.00141,477,000.00
非流动负债:
 长期债务(元) ---会员可见436,221,000.00435,447,000.00434,717,000.00
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见5,833,000.007,059,000.008,297,000.00
 应付账款及票据非流动(元) -会员可见会员可见-1,283,095,000.001,282,152,000.00-
 递延收入非流动(元) 会员可见会员可见会员可见会员可见18,627,000.0016,961,000.0019,890,000.00
 非流动负债其他项目(元) 会员可见会员可见会员可见会员可见377,000.00485,000.001,281,810,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见1,744,153,000.001,742,104,000.001,744,714,000.00
总负债(元) 会员可见会员可见会员可见会员可见1,883,369,000.001,876,468,000.001,886,191,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见195,000.00194,000.00193,000.00
 库存股(元) 会员可见会员可见会员可见会员可见-275,000,000.00-275,000,000.00-275,000,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见1,876,091,000.001,851,058,000.001,820,994,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-2,831,213,000.00-2,669,173,000.00-2,595,717,000.00
 累计其他全面收益(元) 会员可见会员可见-会员可见5,000.00-4,000.002,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见-1,229,922,000.00-1,092,925,000.00-1,049,528,000.00
 少数股东权益(元) 会员可见会员可见会员可见会员可见11,530,000.0010,832,000.0012,670,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见-1,218,392,000.00-1,082,093,000.00-1,036,858,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见664,977,000.00794,375,000.00849,333,000.00
公告日期 2025-10-292025-08-052025-04-292025-02-202024-11-122024-08-012024-05-02
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院